Key facts
- CarePath’s last known valuation is $28.9M.
- It has raised $19.4M; the latest was Later Stage VC ($340K) in Nov 2025.
- Notable investors include Launch Tennessee, InvestTN, JumpStart Capital, Jumpstart Capital (Tennessee), Laborie Medical Technologies — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for CarePath
- ·The full record, as it builds
Funding rounds
No funding rounds for CarePath are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CarePath
Developer of a patient monitoring technology designed for urologic care at home. The company's technology increases patient compliance and data accuracy, confident and appropriate diagnoses, patient satisfaction and comfort, and decreases overall healthcare costs, enabling patients to get access to a system that provides real-time insights into patient symptoms to find optimal treatment and personalized treatment plans, improves patient satisfaction and comfort, and reduces overall healthcare costs.
- Sector
- Healthcare
- HQ
- Knoxville, TN, United States
- Founded
- 2020
- Employees
- 15
- Website
- carepathurology.com/
- Ownership
- Privately Held (backing)
CarePath doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CarePath shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CarePath in its N-PORT filings yet. We sweep new filings monthly.